CLINICAL_TRIALS
trial_result
· 2022-10-21
Clinical Trial Update: Study To Evaluate The Safety And Efficacy Of ILV-094 In Subjects With Rheumatoid Arthritis [Phase 2]
Summary
Phase 2 clinical trial evaluating safety and efficacy of ILV-094 in rheumatoid arthritis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2022-10-21